Bioqual, Inc.
OTC: BIOQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Hanne Andersen-Elyard
- Employees
- 278
- Headquarters
- Rockville, United States
- IPO year
- 2002
- Market cap
- $29.1M
- Website
- https://www.bioqual.com
Loading BIOQ…
Loading profile data…Frequently asked questions about BIOQ
What does Bioqual, Inc. (BIOQ) do?
Bioqual, Inc. delivers a range of preclinical research solutions, encompassing both in-vivo and in-vitro methodologies, to its diverse clientele of commercial enterprises and government agencies across the United States. Their expertise spans numerous critical health domains, including investigations into COVID-19, AIDS, influenza, RSV infection...
Where does BIOQ trade?
Bioqual, Inc. (BIOQ) trades on the Other OTC.
What sector is BIOQ in?
Bioqual, Inc. (BIOQ) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Bioqual, Inc.?
Hanne Andersen-Elyard is the chief executive officer of Bioqual, Inc. (BIOQ).
Where is Bioqual, Inc. headquartered?
Bioqual, Inc. is headquartered in United States.
Does BIOQ pay a dividend?
Yes — Bioqual, Inc. (BIOQ) paid a trailing twelve-month dividend of USD 0.50 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did BIOQ go public?
Bioqual, Inc. (BIOQ) completed its initial public offering in 2002.